Hypoxia in melanoma: using optical spectroscopy and EF5 to assess tumor oxygenation before and during regional chemotherapy for melanoma. - Wikidata - awgldk - TriplyDB

Hypoxia in melanoma: using optical spectroscopy and EF5 to assess tumor oxygenation before and during regional chemotherapy for melanoma.

Hypoxia in melanoma: using optical spectroscopy and EF5 to assess tumor oxygenation before and during regional chemotherapy for melanoma.

http://www.wikidata.org/entity/Q37710877

about

Immunotherapy following regional chemotherapy treatment of advanced extremity melanoma Isolated limb infusion as a model to test new agents to treat metastatic melanoma.Use of infrared microspectroscopy to elucidate a specific chemical signature associated with hypoxia levels found in glioblastoma.

P2860

Q37509709-20FBDA1E-2892-4A85-BF57-EA00E3F03BEC Q38187595-B66EB330-3185-4168-A5CA-58ABEAC0D550 Q38810154-7977D619-A9F9-40DE-9699-E6A5792D3DCB

P2860

Hypoxia in melanoma: using optical spectroscopy and EF5 to assess tumor oxygenation before and during regional chemotherapy for melanoma.

http://www.wikidata.org/entity/Q37710877

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 28 August 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Hypoxia in melanoma: using opt ...... nal chemotherapy for melanoma.

@en

Hypoxia in melanoma: using opt ...... nal chemotherapy for melanoma.

@nl

type

label

Hypoxia in melanoma: using opt ...... nal chemotherapy for melanoma.

@en

Hypoxia in melanoma: using opt ...... nal chemotherapy for melanoma.

@nl

prefLabel

Hypoxia in melanoma: using opt ...... nal chemotherapy for melanoma.

@en

Hypoxia in melanoma: using opt ...... nal chemotherapy for melanoma.

@nl

P1433

Q37710877-F4D67351-24F4-4DEE-87D8-721654EE4C56

P1476

Q37710877-61779820-FF18-41D0-A624-570BB7C3A24B

P2093

Q37710877-1CAA066F-AB10-4BE7-AEFA-A9EB17C6B419

Q37710877-37223359-89C7-4414-84CA-45EB4F0B9F41

Q37710877-4F5B1397-C260-4717-8C08-88D38F7958C1

Q37710877-648C5924-D89E-4F7B-8EEA-76499C1ADFC7

Q37710877-6C12F911-C94D-4095-B3A5-1D3A230AE399

Q37710877-7B404A8A-123D-47F9-8CCE-D5BCC27090CA

Q37710877-F510A29D-969A-4CF6-83DA-A10761C92CD8

P2860

Q37710877-06D9D387-E430-415C-BD4F-BAA0751E01A7

Q37710877-0904609A-46FD-413A-B330-0687AB09E6BA

Q37710877-18A6BDD7-BBB1-4FF0-9A31-4D8444476D7C

Q37710877-1E941E89-660A-4ED1-8CC1-7ABBCAB53EAF

Q37710877-34C6011B-ECC9-44CD-869F-F2B64AF8925F

Q37710877-3D196FF3-56D1-48C4-B655-6DDF98C295C3

Q37710877-5B45D878-4069-4E87-B93B-3C22BBB6EB54

Q37710877-5C798A4E-66B1-43CB-9640-5D88B2078443

Q37710877-5D30DD42-29D5-4E46-9887-63726A6A2EDC

Q37710877-607BB1D2-45EB-4570-A292-2A3198869EEC

P2888

Q37710877-F40B3154-E03E-45BF-96BB-2393BBAAAFCA

P304

Q37710877-BBF730B3-1082-4462-8A3E-1988427911F9

P31

Q37710877-07D6030C-7BB1-48E2-A6F0-CD880DA0A0E2

P356

Q37710877-27926AC9-AB4E-4878-9A09-F8381D632B8B

P433

Q37710877-26621AFE-4F64-42B3-BE5F-E1DFB54DF906

P478

Q37710877-AB6354EA-156D-47E5-A5CB-EEEF4A635309

P50

Q37710877-962CEFAF-72CE-4734-9155-12D5F61AAFB9

Q37710877-FD9F7AC5-561B-464D-BD44-C8401675CD37

P577

Q37710877-DFB96C8F-7CF8-4F59-9E06-2BFAB4735989

P6179

Q37710877-5C5FBCA0-9FE7-4DDD-A166-FEFA6513CEF2

P698

Q37710877-AB8BCBB3-5C7D-45EF-9EE6-3A8BFC0BC652

P921

Q37710877-9AE3AEAC-C7C6-4DDF-8585-0E1263D79A70

Q37710877-DF8F8A86-B1C0-4277-BF39-4B1C08675D29

P932

Q37710877-A664077E-1EB1-4D7D-B16D-361555C0F141

P356

S10434-013-3222-0

P1433

Annals of Surgical Oncology

P1476

Hypoxia in melanoma: using opt ...... nal chemotherapy for melanoma.

@en

P2093

Betty Jiang

http://www.w3.org/2001/XMLSchema#string

Douglas S Tyler

http://www.w3.org/2001/XMLSchema#string

Mark W Dewhirst

http://www.w3.org/2001/XMLSchema#string

Michael E Lidsky

http://www.w3.org/2001/XMLSchema#string

Paul J Mosca

http://www.w3.org/2001/XMLSchema#string

Paul J Speicher

http://www.w3.org/2001/XMLSchema#string

Peter M Scarbrough

http://www.w3.org/2001/XMLSchema#string

P2860

Control of T(H)17/T(reg) balance by hypoxia-inducible factor 1

Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

Molecular pathways: hypoxia response in immune cells fighting or promoting cancer

Regulation of immune cells by local-tissue oxygen tension: HIF1 alpha and adenosine receptors

Improved survival with MEK inhibition in BRAF-mutated melanoma

Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response

Predicting response to breast cancer neoadjuvant chemotherapy using diffuse optical spectroscopy

Diffuse optical spectroscopic imaging correlates with final pathological response in breast cancer neoadjuvant chemotherapy.

Baseline tumor oxygen saturation correlates with a pathologic complete response in breast cancer patients undergoing neoadjuvant chemotherapy.

P2888

s10434-013-3222-0

P304

1435-1440

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1245/S10434-013-3222-0

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P50

Gregory M Palmer

Georgia Beasley

P577

2013-08-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1029655743

http://www.w3.org/2001/XMLSchema#string

P698

23982250

http://www.w3.org/2001/XMLSchema#string

P921

P932

3992126

http://www.w3.org/2001/XMLSchema#string